argenx SE American Depositary Shares
ARGX · Nasdaq
ARGX · Nasdaq
argenx fell $27.73, or 3.18%, from $872.23 on July 28 to $844.50 on August 4. The stock initially rose 1.18% on July 29, then reversed, slipping 1.13% on July 30 and 2.15% on July 31 before giving back the full early gain with a further 2.70% decline on August 3. It recovered 1.65% on August 4 but remained below the prior close. The supplied evidence identifies no company-specific announcement driving the move. Instead, broader biotechnology positioning may have weighed on sentiment: BNK Invest reported approximately $141.5 million of weekly outflows from the iShares Biotechnology ETF, a 1.5% decline in shares outstanding. Zacks’ Buy upgrade provided a positive counterpoint.
